Giant cell arteritis. Part II. Treatment
Treatment options for giant cell arteritis (GCA) and its complications are considered. GCA is treatable with glucocorticoids (GC). The data available in the literature suggest that it is necessary to hospitalize GCA patients with acute vision loss or brain ischemia to administer intravenous megadose...
Main Author: | Azamat Makhmudovich Satybaldyev |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2012-12-01
|
Series: | Современная ревматология |
Subjects: | |
Online Access: | https://mrj.ima-press.net/mrj/article/view/447 |
Similar Items
-
Giant cell arteritis. Part I. Terminology, classification, clinical manifestations, diagnosis
by: Azamat Makhmudovich Satybaldyev
Published: (2012-09-01) -
Giant cell arteritis. Part III. New trends in its treatment (role of genetically engineered drugs)
by: Azamat Makhmudovich Satybaldyev
Published: (2013-03-01) -
The Meteoritics Trial: efficacy of methotrexate after remission-induction with tocilizumab and glucocorticoids in giant cell arteritis—study protocol for a randomized, double-blind, placebo-controlled, parallel-group phase II study
by: Lena Kreis, et al.
Published: (2024-01-01) -
The importance of patient engagement in the management of giant cell arteritis
by: Nikhil Patil, et al.
Published: (2022-11-01) -
International guidelines for the management of giant cell arteritis and polymyalgia rheumatica: The 2015 results
by: T. V. Beketova, et al.
Published: (2016-10-01)